Firivumab (CT-P22, CT120), a human IgG1 monoclonal antibody targeting influenza A virus hemagglutinin (Anti-IAV HA), demonstrates neutralization capabilities against multiple strains including H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2, and H12N7. It has also shown to protect mice from the H1N1 virus [1] [2] [3].
CAS Number:
[1443004-15-6]
Target:
Influenza Virus
* VAT and and shipping costs not included. Errors and price changes excepted
